Get Live Data

George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here. 

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

  2. Share Prices
  3. PureTech Share Price
  4. PureTech Share Regulatory News
  5. Transaction in Own Shares

Pin to quick picksPureTech Regulatory News (PRTC)

PureTech Information

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 218.00
Bid: 215.00
Ask: 217.50
Change: 5.50 (2.59%)
Spread: 2.50 (1.163%)
Open: 219.50
High: 219.50
Low: 207.00
Prev. Close: 212.50
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

19 Dec 2023 07:00

RNS Number : 2172X
PureTech Health PLC
19 December 2023
 

19 December 2023

 

PureTech Health plc

 

Transaction in Own Shares

 

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

 

Date of purchase:

18 December 2023

Number of ordinary shares purchased:

51,345

Highest price paid per share:

150.80p

Lowest price paid per share:

148.00p

Volume weighted average price paid per share:

150.04p

 

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 17,394,375 ordinary shares in treasury and has 272,073,784 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 272,073,784 which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

 

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 27 therapeutics and therapeutic candidates, including two (Plenity® and EndeavorRx®) that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval. A number of these programs are being advanced by PureTech or its Founded Entities in various indications and stages of clinical development, including registration enabling studies. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points.

 

For more information, visit www.puretechhealth.com or connect with us on X, formerly known as Twitter, @puretechh.

 

Contact:

PureTech

Investor Relations

IR@puretechhealth.com

Individual Transactions

 

Transaction Date

Transaction Time

Volume

Price (GBp)

Platform

Transaction Reference Number

18/12/2023

08:14:43

770

148

XLON

00382815671TRLO0.1.1

18/12/2023

08:22:01

770

148

XLON

00382816554TRLO0.1.1

18/12/2023

08:29:23

770

148

XLON

00382817362TRLO0.1.1

18/12/2023

08:37:07

1

148.6

CHIX

00382818057TRLO0.1.1

18/12/2023

08:37:07

20

148.6

CHIX

00382818058TRLO0.1.1

18/12/2023

08:37:07

217

148.6

CHIX

00382818059TRLO0.1.1

18/12/2023

08:37:23

770

148.6

XLON

00382818086TRLO0.1.1

18/12/2023

08:52:32

770

150

XLON

00382819525TRLO0.1.1

18/12/2023

08:53:20

770

150

XLON

00382819682TRLO0.1.1

18/12/2023

08:57:04

762

150

CHIX

00382820271TRLO0.1.1

18/12/2023

09:00:59

770

150

XLON

00382821056TRLO0.1.1

18/12/2023

09:24:44

688

150.6

CHIX

00382824568TRLO0.1.1

18/12/2023

09:24:44

574

150.6

XLON

00382824569TRLO0.1.1

18/12/2023

09:50:28

966

150.4

XLON

00382827134TRLO0.1.1

18/12/2023

09:50:28

126

150.4

XLON

00382827135TRLO0.1.1

18/12/2023

09:50:28

329

150.4

AQXE

00382827136TRLO0.1.1

18/12/2023

09:50:28

631

150.2

BATE

00382827137TRLO0.1.1

18/12/2023

09:50:28

153

150.2

TRQX

00382827138TRLO0.1.1

18/12/2023

09:50:28

21

150.2

TRQX

00382827139TRLO0.1.1

18/12/2023

10:00:41

622

150.2

CHIX

00382828324TRLO0.1.1

18/12/2023

10:00:41

644

150.2

XLON

00382828325TRLO0.1.1

18/12/2023

10:36:12

770

150.2

CHIX

00382831645TRLO0.1.1

18/12/2023

10:36:13

235

150.2

XLON

00382831649TRLO0.1.1

18/12/2023

10:37:08

10

150.2

XLON

00382831703TRLO0.1.1

18/12/2023

12:22:46

329

150.2

AQXE

00382843407TRLO0.1.1

18/12/2023

12:22:46

770

150.2

CHIX

00382843408TRLO0.1.1

18/12/2023

12:39:07

111

150

BATE

00382845644TRLO0.1.1

18/12/2023

12:39:07

520

150

BATE

00382845645TRLO0.1.1

18/12/2023

12:39:07

56

150

BATE

00382845646TRLO0.1.1

18/12/2023

12:39:07

24

150

TRQX

00382845647TRLO0.1.1

18/12/2023

12:39:07

174

150

TRQX

00382845648TRLO0.1.1

18/12/2023

12:39:07

16

150

TRQX

00382845649TRLO0.1.1

18/12/2023

12:39:07

1540

150

XLON

00382845650TRLO0.1.1

18/12/2023

12:45:35

1540

149.6

XLON

00382847484TRLO0.1.1

18/12/2023

14:30:02

329

150.2

AQXE

00382866352TRLO0.1.1

18/12/2023

14:30:02

329

150.2

AQXE

00382866355TRLO0.1.1

18/12/2023

14:30:02

20

150.2

AQXE

00382866357TRLO0.1.1

18/12/2023

14:30:02

120

150.2

CHIX

00382866360TRLO0.1.1

18/12/2023

14:30:02

73

150.2

CHIX

00382866362TRLO0.1.1

18/12/2023

14:30:02

105

150.2

CHIX

00382866363TRLO0.1.1

18/12/2023

14:30:02

472

150.2

CHIX

00382866366TRLO0.1.1

18/12/2023

14:30:02

770

150.2

CHIX

00382866368TRLO0.1.1

18/12/2023

14:30:02

28

150.2

TRQX

00382866370TRLO0.1.1

18/12/2023

14:30:02

106

150.2

TRQX

00382866372TRLO0.1.1

18/12/2023

14:30:02

2

150.2

TRQX

00382866374TRLO0.1.1

18/12/2023

14:30:02

63

150.2

TRQX

00382866389TRLO0.1.1

18/12/2023

14:30:02

28

150.2

TRQX

00382866391TRLO0.1.1

18/12/2023

14:30:07

615

150.6

CHIX

00382867655TRLO0.1.1

18/12/2023

14:30:07

49

150.8

CHIX

00382867659TRLO0.1.1

18/12/2023

14:30:07

35

150.8

CHIX

00382867662TRLO0.1.1

18/12/2023

14:30:07

178

150.8

CHIX

00382867664TRLO0.1.1

18/12/2023

14:30:44

217

150.8

CHIX

00382873289TRLO0.1.1

18/12/2023

14:30:44

60

150.8

CHIX

00382873290TRLO0.1.1

18/12/2023

14:36:18

217

150.8

CHIX

00382889704TRLO0.1.1

18/12/2023

14:36:53

217

150.8

CHIX

00382890776TRLO0.1.1

18/12/2023

14:37:28

217

150.8

CHIX

00382891973TRLO0.1.1

18/12/2023

14:39:07

217

150.8

CHIX

00382895034TRLO0.1.1

18/12/2023

14:39:07

41

150.8

CHIX

00382895036TRLO0.1.1

18/12/2023

14:42:41

217

150.8

CHIX

00382899790TRLO0.1.1

18/12/2023

14:42:41

58

150.8

CHIX

00382899791TRLO0.1.1

18/12/2023

14:43:14

217

150.8

CHIX

00382900533TRLO0.1.1

18/12/2023

14:45:27

575

150.8

BATE

00382903494TRLO0.1.1

18/12/2023

14:52:42

309

150.8

AQXE

00382910658TRLO0.1.1

18/12/2023

14:52:42

1295

150.8

CHIX

00382910659TRLO0.1.1

18/12/2023

14:52:42

255

150.8

TRQX

00382910660TRLO0.1.1

18/12/2023

14:59:16

631

150.8

BATE

00382916333TRLO0.1.1

18/12/2023

15:26:07

210

150.4

AQXE

00382933268TRLO0.1.1

18/12/2023

15:38:43

143

150.4

CHIX

00382939427TRLO0.1.1

18/12/2023

15:38:43

770

150.4

CHIX

00382939428TRLO0.1.1

18/12/2023

15:38:43

119

150.4

AQXE

00382939429TRLO0.1.1

18/12/2023

15:38:43

71

150.4

CHIX

00382939430TRLO0.1.1

18/12/2023

15:38:43

631

150.4

BATE

00382939431TRLO0.1.1

18/12/2023

15:38:43

174

150.4

TRQX

00382939432TRLO0.1.1

18/12/2023

15:38:46

1654

150

XLON

00382939498TRLO0.1.1

18/12/2023

15:38:46

1392

150

XLON

00382939499TRLO0.1.1

18/12/2023

15:38:46

1392

150

XLON

00382939500TRLO0.1.1

18/12/2023

15:38:46

1654

150

XLON

00382939501TRLO0.1.1

18/12/2023

15:44:05

329

150.2

AQXE

00382941981TRLO0.1.1

18/12/2023

15:44:07

1082

150

XLON

00382941995TRLO0.1.1

18/12/2023

15:56:58

329

150

AQXE

00382946911TRLO0.1.1

18/12/2023

15:56:58

631

150.2

BATE

00382946912TRLO0.1.1

18/12/2023

15:56:58

1326

150.2

CHIX

00382946913TRLO0.1.1

18/12/2023

15:56:58

770

150.2

CHIX

00382946914TRLO0.1.1

18/12/2023

15:56:58

631

150.2

BATE

00382946915TRLO0.1.1

18/12/2023

15:56:58

1964

150

XLON

00382946917TRLO0.1.1

18/12/2023

15:56:58

174

150.2

TRQX

00382946916TRLO0.1.1

18/12/2023

15:56:58

770

150

XLON

00382946918TRLO0.1.1

18/12/2023

15:56:58

276

150

XLON

00382946919TRLO0.1.1

18/12/2023

15:56:58

234

150

XLON

00382946920TRLO0.1.1

18/12/2023

15:56:58

260

150

XLON

00382946921TRLO0.1.1

18/12/2023

15:56:58

295

150

XLON

00382946922TRLO0.1.1

18/12/2023

15:56:58

475

150

XLON

00382946923TRLO0.1.1

18/12/2023

15:56:58

1835

150

XLON

00382946924TRLO0.1.1

18/12/2023

15:56:58

1211

150

XLON

00382946925TRLO0.1.1

18/12/2023

15:56:58

1160

150

XLON

00382946926TRLO0.1.1

18/12/2023

15:56:58

314

150

XLON

00382946927TRLO0.1.1

18/12/2023

15:56:58

636

150

XLON

00382946928TRLO0.1.1

18/12/2023

15:57:02

904

150

XLON

00382946978TRLO0.1.1

18/12/2023

15:57:28

1033

150

XLON

00382947151TRLO0.1.1

18/12/2023

15:57:28

1192

150

XLON

00382947150TRLO0.1.1

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFVAFTLTLIV
12345678910
Date   Source Headline
25th Apr 20247:00 amRNSFinal Results
18th Apr 20247:00 amRNSNotice of Results
16th Apr 202412:00 pmRNSPRTC LYT-100 Ph2b in IPF Enrolled; Results Q4 2024
11th Apr 202412:00 pmRNSFDA Grants PRTC's LYT-200 Fast Track Designation
9th Apr 20247:00 amRNSPRTC Launches Seaport w/ $100M; Leadership Changes
19th Mar 20247:00 amRNS$100M Tender Offer
18th Mar 20241:32 pmRNS$14B Acquisition of PRTC’s Karuna by BMS Completed
13th Mar 202411:00 amRNSFDA Grants PRTC's LYT-200 Orphan Drug Designation
6th Mar 20247:00 amRNSPDMR Notification RSU Vesting
27th Feb 202412:00 pmRNSPRTC to Present at Cowen and Leerink Conferences
27th Feb 20247:00 amRNSPRTC: Akili Positive Ph3 & Japan PMDA Submission
8th Feb 20247:00 amRNSTransaction in Own Shares
7th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 20247:00 amRNSTransaction in Own Shares
31st Jan 20247:00 amRNSTransaction in Own Shares
30th Jan 20247:00 amRNSTransaction in Own Shares
29th Jan 20245:30 pmRNSTransaction in Own Shares
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 20247:00 amRNSTransaction in Own Shares
19th Jan 20247:00 amRNSTransaction in Own Shares
18th Jan 20247:00 amRNSTransaction in Own Shares
17th Jan 20247:00 amRNSTransaction in Own Shares
16th Jan 20247:00 amRNSTransaction in Own Shares
15th Jan 20247:00 amRNSTransaction in Own Shares
12th Jan 20247:00 amRNSTransaction in Own Shares
11th Jan 20247:00 amRNSTransaction in Own Shares
10th Jan 20247:00 amRNSTransaction in Own Shares
9th Jan 20247:00 amRNSTransaction in Own Shares
8th Jan 20247:00 amRNSTransaction in Own Shares
5th Jan 20247:00 amRNSTransaction in Own Shares
4th Jan 20247:00 amRNSTransaction in Own Shares
3rd Jan 202412:00 pmRNSPureTech to present at the JP Morgan Conference
3rd Jan 20247:00 amRNSTransaction in Own Shares
27th Dec 20237:00 amRNSTransaction in Own Shares
22nd Dec 20231:31 pmRNSBMY Acquires PRTC Founded Entity Karuna for $14B
22nd Dec 20237:00 amRNSTransaction in Own Shares
21st Dec 20237:00 amRNSTransaction in Own Shares
20th Dec 20237:00 amRNSPRTC Year End Update & Outlook for 2024
20th Dec 20237:00 amRNSTransaction in Own Shares
19th Dec 20237:00 amRNSTransaction in Own Shares
18th Dec 20237:00 amRNSTransaction in Own Shares
15th Dec 20237:00 amRNSTransaction in Own Shares
14th Dec 20237:00 amRNSTransaction in Own Shares
13th Dec 20237:00 amRNSTransaction in Own Shares
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.